Efficient growth suppression and apoptosis in human laryngeal carcinoma cell line HEP-2 induced by an adeno-associated virus expressing human FAS ligand (Q39408042)

From Wikidata

Jump to navigation Jump to search

scientific article published on 20 January 2012

Language	Label	Description	Also known as
English	Efficient growth suppression and apoptosis in human laryngeal carcinoma cell line HEP-2 induced by an adeno-associated virus expressing human FAS ligand	scientific article published on 20 January 2012

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Efficient growth suppression and apoptosis in human laryngeal carcinoma cell line HEP-2 induced by an adeno-associated virus expressing human FAS ligand (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

laryngeal carcinoma

1 reference

based on heuristic

inferred from title

author name string

Haili Sun

1

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Yuhe Liu

2

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Dingfang Bu

3

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Xiang Liu

4

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

James S Norris

5

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Shuifang Xiao

6

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

publication date

20 January 2012

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

34

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

1628-1633

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Molecular introduction to head and neck cancer (HNSCC) carcinogenesis.

1 reference

https://api.crossref.org/works/10.1002%2FHED.21985

21 January 2018

Precise hit: adeno-associated virus in gene targeting

1 reference

https://api.crossref.org/works/10.1002%2FHED.21985

21 January 2018

In vitro efficacy of Fas ligand gene therapy for the treatment of bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FHED.21985

21 January 2018

Adenovirus-mediated FasL gene transfer into human gastric carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHED.21985

21 January 2018

Nonviral genetic transfer of Fas ligand induced significant growth suppression and apoptotic tumor cell death in prostate cancer in vivo

1 reference

https://api.crossref.org/works/10.1002%2FHED.21985

21 January 2018

Paclitaxel (Taxol)-induced apoptosis in human epithelioid sarcoma cell lines is enhanced by upregulation of CD95 ligand (FasL/Apo-1L).

1 reference

https://api.crossref.org/works/10.1002%2FHED.21985

21 January 2018

Enhanced apoptosis of glioma cell lines is achieved by co-delivering FasL-GFP and TRAIL with a complex Ad5 vector

1 reference

https://api.crossref.org/works/10.1002%2FHED.21985

21 January 2018

FasL gene therapy: a new therapeutic modality for head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FHED.21985

21 January 2018

Role of acid ceramidase in resistance to FasL: therapeutic approaches based on acid ceramidase inhibitors and FasL gene therapy

1 reference

https://api.crossref.org/works/10.1002%2FHED.21985

21 January 2018

CD95/Fas signaling in human melanoma cells: conditional expression of CD95L/FasL overcomes the intrinsic apoptosis resistance of malignant melanoma and inhibits growth and progression of human melanoma xenotransplants

1 reference

https://api.crossref.org/works/10.1002%2FHED.21985

21 January 2018

Efficient and selective tumor cell lysis and induction of apoptosis in melanoma cells by a conditional replication-competent CD95L adenovirus

1 reference

https://api.crossref.org/works/10.1002%2FHED.21985

21 January 2018

The many roles of FAS receptor signaling in the immune system

1 reference

https://api.crossref.org/works/10.1002%2FHED.21985

21 January 2018

Up-regulation of Fas ligand and down-regulation of Fas expression in oral carcinogenesis

1 reference

https://api.crossref.org/works/10.1002%2FHED.21985

21 January 2018

Fas ligand promotes tumor immune evasion of colon cancer in vivo.

1 reference

https://api.crossref.org/works/10.1002%2FHED.21985

21 January 2018

The role of Fas ligand and transforming growth factor beta in tumor progression: molecular mechanisms of immune privilege via Fas-mediated apoptosis and potential targets for cancer therapy

1 reference

https://api.crossref.org/works/10.1002%2FHED.21985

21 January 2018

Gene transfer of Fas ligand induces tumor regression in vivo

1 reference

https://api.crossref.org/works/10.1002%2FHED.21985

21 January 2018

Fas ligand delivery by a prostate-restricted replicative adenovirus enhances safety and antitumor efficacy

1 reference

https://api.crossref.org/works/10.1002%2FHED.21985

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HED.21985

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39408042&oldid=1826303382"